
Emerging Venture Philanthropists Investing for Patient Impact

The Future of Rare Disease R&D: Protecting Progress, Achieving Access

A Conversation with FDA Commissioner Stephen Hahn

Panel: Reducing Drag: New Approaches to IP Negotiation and Technology Licensing

Delivering Star Wars medicine into a Flintstones health care system

Getting Our Health Priorities in Order: Prevention, Research, and Treatment

Panel - Mental Health: Research and Development at a Crossroads

A Conversation with FDA Commissioner Scott Gottlieb

PLENARY - Molecule to man (and woman): Speeding translation to human trials
